Oncogene : Impact Factor & More
eISSN: 1476-5594pISSN: 0950-9232
Share this on:
Key Metrics
CiteScore 
15.6
Impact Factor
5 - 10
Scite Index
0.94 5-Year SI
SNIP
1.79
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Oncogene
Oncogene Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncogene ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncogene
LINC-AC092535.5 regulates MICAL2 mRNA level to inhibit p53-mediated ferroptosis in nasopharyngeal carcinoma.
- 14 Mar 2026
- Oncogene
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.
- 13 Mar 2026
- Oncogene
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD).
- 9 Mar 2026
- Oncogene
PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression
- 6 Mar 2026
- Oncogene
Correction: Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
- 4 Mar 2026
- Oncogene
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.
- 4 Mar 2026
- Oncogene
LINC-AC092535.5 regulates MICAL2 mRNA level to inhibit p53-mediated ferroptosis in nasopharyngeal carcinoma.
- 14 Mar 2026
- Oncogene
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.
- 13 Mar 2026
- Oncogene
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD).
- 9 Mar 2026
- Oncogene
PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression
- 6 Mar 2026
- Oncogene
Correction: Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
- 4 Mar 2026
- Oncogene
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.
- 4 Mar 2026
- Oncogene
FAQs on Oncogene
How long has Oncogene been actively publishing? 
What is the publishing frequency of Oncogene?
How many articles did Oncogene publish last year?
What is the eISSN & pISSN for Oncogene?
What is Citescore for Oncogene?
What is SNIP score for Oncogene?
Who is the publisher of Oncogene?
